SuicidDentistV1, Main, Exploration, bibRecord, 000531

Antimicrobial resistance with focus on oral beta-lactamases.

Identifieur interne : 000531 ( Main/Exploration ); précédent : 000530; suivant : 000532

Antimicrobial resistance with focus on oral beta-lactamases.

Auteurs : T. Handal [Norvège] ; I. Olsen

Source :

European journal of oral sciences [ 0909-8836 ] ; 2000.

RBID : pubmed:10872985

Descripteurs français

KwdFr :
- Antibactériens (composition chimique), Antibactériens (pharmacologie), Bactéries (enzymologie), Bouche (microbiologie), Humains (MeSH), Inhibiteurs des bêta-lactamases (MeSH), Paroi cellulaire (effets des médicaments et des substances chimiques), Résistance aux bêta-lactamines (physiologie), bêta-Lactamases (métabolisme), bêta-Lactames (MeSH).
MESH :
- composition chimique : Antibactériens.
- effets des médicaments et des substances chimiques : Paroi cellulaire.
- enzymologie : Bactéries.
- microbiologie : Bouche.
- métabolisme : bêta-Lactamases.
- pharmacologie : Antibactériens.
- physiologie : Résistance aux bêta-lactamines.
- Humains, Inhibiteurs des bêta-lactamases, bêta-Lactames.

English descriptors

KwdEn :
- Anti-Bacterial Agents (chemistry), Anti-Bacterial Agents (pharmacology), Bacteria (enzymology), Cell Wall (drug effects), Humans (MeSH), Mouth (microbiology), beta-Lactam Resistance (physiology), beta-Lactamase Inhibitors (MeSH), beta-Lactamases (metabolism), beta-Lactams (MeSH).
MESH :
- chemical , chemistry : Anti-Bacterial Agents.
- chemical , metabolism : beta-Lactamases.
- chemical , pharmacology : Anti-Bacterial Agents.
- drug effects : Cell Wall.
- enzymology : Bacteria.
- microbiology : Mouth.
- physiology : beta-Lactam Resistance.
- Humans, beta-Lactamase Inhibitors, beta-Lactams.

Abstract

Over the last 10-15 yr antibiotic resistance has increased in the oral microflora. The beta-lactam antibiotics, i.e., penicillins and cephalosporins, are the most frequently used antimicrobial agents. Unfortunately, the efficiency of these drugs is increasingly being challenged by the emergence of resistant bacteria, which is mainly due to their production of beta-lactamases. In this paper, mechanisms of antibiotic resistance are reviewed, with emphasis on beta-lactamases. This review also discusses how the presence of beta-lactamases in oral microorganisms may affect the treatment of oral diseases. Dentists can influence the emerging global crisis of antibiotic resistance by carefully evaluating the indications for antibiotic treatment. General guidelines for when and how to use antibiotics in dentistry are reviewed.

DOI: 10.1034/j.1600-0722.2000.108003163.x
PubMed: 10872985

Affiliations:

Norvège

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000534
to stream Main, to step Curation: 000534

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antimicrobial resistance with focus on oral beta-lactamases.</title>
<author><name sortKey="Handal, T" sort="Handal, T" uniqKey="Handal T" first="T" last="Handal">T. Handal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oral Biology, Dental Faculty, University of Oslo, Norway. thandal@odont.uio.no</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Oral Biology, Dental Faculty, University of Oslo</wicri:regionArea>
<wicri:noRegion>University of Oslo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olsen, I" sort="Olsen, I" uniqKey="Olsen I" first="I" last="Olsen">I. Olsen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10872985</idno>
<idno type="pmid">10872985</idno>
<idno type="doi">10.1034/j.1600-0722.2000.108003163.x</idno>
<idno type="wicri:Area/Main/Corpus">000534</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000534</idno>
<idno type="wicri:Area/Main/Curation">000534</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000534</idno>
<idno type="wicri:Area/Main/Exploration">000534</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antimicrobial resistance with focus on oral beta-lactamases.</title>
<author><name sortKey="Handal, T" sort="Handal, T" uniqKey="Handal T" first="T" last="Handal">T. Handal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oral Biology, Dental Faculty, University of Oslo, Norway. thandal@odont.uio.no</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Oral Biology, Dental Faculty, University of Oslo</wicri:regionArea>
<wicri:noRegion>University of Oslo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Olsen, I" sort="Olsen, I" uniqKey="Olsen I" first="I" last="Olsen">I. Olsen</name>
</author>
</analytic>
<series><title level="j">European journal of oral sciences</title>
<idno type="ISSN">0909-8836</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (chemistry)</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Bacteria (enzymology)</term>
<term>Cell Wall (drug effects)</term>
<term>Humans (MeSH)</term>
<term>Mouth (microbiology)</term>
<term>beta-Lactam Resistance (physiology)</term>
<term>beta-Lactamase Inhibitors (MeSH)</term>
<term>beta-Lactamases (metabolism)</term>
<term>beta-Lactams (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (composition chimique)</term>
<term>Antibactériens (pharmacologie)</term>
<term>Bactéries (enzymologie)</term>
<term>Bouche (microbiologie)</term>
<term>Humains (MeSH)</term>
<term>Inhibiteurs des bêta-lactamases (MeSH)</term>
<term>Paroi cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Résistance aux bêta-lactamines (physiologie)</term>
<term>bêta-Lactamases (métabolisme)</term>
<term>bêta-Lactames (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>beta-Lactamases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Wall</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Paroi cellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Bactéries</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Bacteria</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Bouche</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Mouth</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>bêta-Lactamases</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Résistance aux bêta-lactamines</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>beta-Lactam Resistance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>beta-Lactamase Inhibitors</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Inhibiteurs des bêta-lactamases</term>
<term>bêta-Lactames</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Over the last 10-15 yr antibiotic resistance has increased in the oral microflora. The beta-lactam antibiotics, i.e., penicillins and cephalosporins, are the most frequently used antimicrobial agents. Unfortunately, the efficiency of these drugs is increasingly being challenged by the emergence of resistant bacteria, which is mainly due to their production of beta-lactamases. In this paper, mechanisms of antibiotic resistance are reviewed, with emphasis on beta-lactamases. This review also discusses how the presence of beta-lactamases in oral microorganisms may affect the treatment of oral diseases. Dentists can influence the emerging global crisis of antibiotic resistance by carefully evaluating the indications for antibiotic treatment. General guidelines for when and how to use antibiotics in dentistry are reviewed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10872985</PMID>
<DateCompleted><Year>2000</Year>
<Month>10</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>11</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0909-8836</ISSN>
<JournalIssue CitedMedium="Print"><Volume>108</Volume>
<Issue>3</Issue>
<PubDate><Year>2000</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>European journal of oral sciences</Title>
<ISOAbbreviation>Eur J Oral Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Antimicrobial resistance with focus on oral beta-lactamases.</ArticleTitle>
<Pagination><MedlinePgn>163-74</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Over the last 10-15 yr antibiotic resistance has increased in the oral microflora. The beta-lactam antibiotics, i.e., penicillins and cephalosporins, are the most frequently used antimicrobial agents. Unfortunately, the efficiency of these drugs is increasingly being challenged by the emergence of resistant bacteria, which is mainly due to their production of beta-lactamases. In this paper, mechanisms of antibiotic resistance are reviewed, with emphasis on beta-lactamases. This review also discusses how the presence of beta-lactamases in oral microorganisms may affect the treatment of oral diseases. Dentists can influence the emerging global crisis of antibiotic resistance by carefully evaluating the indications for antibiotic treatment. General guidelines for when and how to use antibiotics in dentistry are reviewed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Handal</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Oral Biology, Dental Faculty, University of Oslo, Norway. thandal@odont.uio.no</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Olsen</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Eur J Oral Sci</MedlineTA>
<NlmUniqueID>9504563</NlmUniqueID>
<ISSNLinking>0909-8836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D065093">beta-Lactamase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047090">beta-Lactams</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.2.6</RegistryNumber>
<NameOfSubstance UI="D001618">beta-Lactamases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002473" MajorTopicYN="N">Cell Wall</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009055" MajorTopicYN="N">Mouth</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018440" MajorTopicYN="N">beta-Lactam Resistance</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065093" MajorTopicYN="N">beta-Lactamase Inhibitors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001618" MajorTopicYN="N">beta-Lactamases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047090" MajorTopicYN="N">beta-Lactams</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>54</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2000</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>11</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2000</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10872985</ArticleId>
<ArticleId IdType="doi">10.1034/j.1600-0722.2000.108003163.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Norvège</li>
</country>
</list>
<tree><noCountry><name sortKey="Olsen, I" sort="Olsen, I" uniqKey="Olsen I" first="I" last="Olsen">I. Olsen</name>
</noCountry>
<country name="Norvège"><noRegion><name sortKey="Handal, T" sort="Handal, T" uniqKey="Handal T" first="T" last="Handal">T. Handal</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000531 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000531 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SuicidDentistV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:10872985
   |texte=   Antimicrobial resistance with focus on oral beta-lactamases.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:10872985" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SuicidDentistV1

This area was generated with Dilib version V0.6.39.
Data generation: Sun Oct 3 17:04:29 2021. Site generation: Sun Oct 3 17:05:17 2021

	Serveur d'exploration sur le suicide chez les dentistes
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le suicide chez les dentistes

Antimicrobial resistance with focus on oral beta-lactamases.

Antimicrobial resistance with focus on oral beta-lactamases.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki